Incidence and Risk Factors of Refeeding Syndrome
NCT02073032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2014-02-27
Summary
The main objective of this observational survey was to determine the incidence rate of refeeding phenomena (RFF) (defined as any decline in p-phosphate) and RFS (defined as any decline in p-phosphate with additional development of any of the following clinical symptoms: oedema, confusion, dyspnoea, hypotension, arrhythmia, seizures) among recently admitted or referred HNC patients to the Department of Otorhinolaryngology for surgery. The second objective was to determine if informations at admittance could identify HNC patients at high risk of developing RFF and RFS.
Conditions
- Cancer of the Head and Neck
Interventions
- OTHER
-
No intervention, only observation
Sponsors & Collaborators
-
University of Copenhagen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care
NCT01803061 ·Status: COMPLETED ·Phase: NA
-
Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status
NCT03068559 ·Status: COMPLETED
-
Nutrition and Life QUality Patients With Head and Neck Cancers
NCT02510859 ·Status: COMPLETED ·Phase: NA
-
Calcium Electroporation for Head and Neck Cancer
NCT03051269 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer
NCT06170203 ·Status: RECRUITING
-
Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark
NCT05423704 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Trial Comparing Different Follow-up Strategies
NCT05388136 ·Status: TERMINATED ·Phase: NA
-
Head and Neck Cancer Treatment Related Dysphagia
NCT02657850 ·Status: WITHDRAWN
-
A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)
NCT01820312 ·Status: WITHDRAWN ·Phase: PHASE2
-
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
NCT02031250 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
NCT02965001 ·Status: COMPLETED ·Phase: PHASE2
-
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 ·Status: UNKNOWN ·Phase: NA
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
NCT04185974 ·Status: RECRUITING ·Phase: NA
-
Proton Re-Irradiation for Recurrent Head and Neck Cancer
NCT03217188 ·Status: COMPLETED ·Phase: PHASE2
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence
NCT06224166 ·Status: RECRUITING
-
Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176 ·Status: COMPLETED ·Phase: NA
-
Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients
NCT02025062 ·Status: COMPLETED ·Phase: NA
-
H&N Cancer; Survivorship and Late Effects
NCT04758026 ·Status: COMPLETED
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
NCT02201355 ·Status: TERMINATED ·Phase: PHASE1
-
Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer
NCT04952922 ·Status: COMPLETED
-
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol
NCT01268878 ·Status: COMPLETED